Optiscan Imaging is recruiting patients into a Melbourne trial of its innovative precision surgery and pathology devices to ...

Pathology & Lab Medicine : Welcome to Medscape Pathology & Lab Medicine, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text ...

Patients’ rights advocate Alex Lam says such cases should also be proactively escalated to professional watchdogs for ...

Optiscan has initiated its first in-human breast cancer study at the Royal Melbourne Hospital, marking the start of patient ...

The ulcer grew. In fact, it seemed as though his leg was caving in as the flesh around it began rotting away. A month before ...

Kimalu (KEE-ma-loo), a 12-year-old female beluga whale, is resting comfortably following a historic procedure at Chicago's ...

NEW YORK CITY -- Heart valve innovation has made polymer valves a reality, with one such device boasting good 1-year outcomes ...

Spinal disorders often begin subtly, with symptoms that are easily overlooked, or dismissed as routine strain .

Post-treatment breast MRI often underestimates tumor size in invasive lobular carcinoma, especially with non-mass enhancement, impacting surgical margins after neoadjuvant therapy.

The company said Stumpe’s promotion is a “pivotal step in [its] digital transformation and its ambition to lead the next era ...